| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 2579683 | Thérapie | 2006 | 10 Pages |
Abstract
Pathways have been proposed to improve the efficiency of clinical research in France and Europe, involving the public hospital sector, and this requires the connection of disease-oriented networks and integrated infrastructures in Europe. As stated in the IMI strategic research agenda on efficacy, the quality of public infrastructures in Europe will be a key factor for its competitiveness and attractiveness for both academic and industry projects.
Keywords
Related Topics
Health Sciences
Pharmacology, Toxicology and Pharmaceutical Science
Pharmacology, Toxicology and Pharmaceutics (General)
Authors
Jacques Demotes-Mainard, Emmanuel Canet, Lionel Segard,